Drug developer Moderna Inc has said it has so far enrolled 13,194 participants in the ongoing late-stage 30,000-volunteer US trial testing its Covid-19 vaccine candidate, Reuters reported.

In a tweet, the company also said that 18 per cent of the participants currently enrolled are Black, Latino, American Indian or Alaska Native, groups among the hardest hit by the coronavirus virus pandemic.